Cardiomyopathy Arrhythmia Risk Evaluation

University Health Network, Toronto164 enrolled

Overview

This study will evaluate the prognostic utility of novel ECG markers of electrical instability in patients with cardiomyopathy.

Baseline ECG markers of electrical instability will be measured in patients with cardiomyopathy. These ECG markers will be evaluated from a clinical Holter recording. All patients will have a primary implantable cardioverter defibrillator (ICD) as part of their clinical care. Patients will be followed prospectively for 2 years to evaluate the primary outcome of appropriate ICD shocks. Multivariable modelling will be performed to determine whether the ECG markers of electrical instability independently predict the primary clinical outcome.

Study Type

OBSERVATIONAL

Enrollment

164

Conditions

Cardiomyopathy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * cardiomyopathy, primary prevention ICD Exclusion Criteria: * brady-pacing requirement

Locations (1)

University Health Network

Toronto, Ontario, Canada

Outcomes

Primary Outcomes

Proportion of patients with appropriate implantable cardioverter defibrillator (ICD) shocks

Proportion is from 0 (no patients with shocks) to 100% (all patients receive shocks)

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.